• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for May 2015

European Parliament Trade Committee Tries To Defuse TTIP Controversy But Outcome Remains Uncertain

29/05/2015 by Dugie Standeford for Intellectual Property Watch 1 Comment

European Commission negotiators should back away from a controversial provision in the Transatlantic Trade and Investment Partnership (TTIP) deal that would allow companies to sue governments in arbitration courts over claimed unequal treatment, the European Parliament International Trade Committee (INTA) said on 28 May. MEPs called instead for publicly appointed, independent judges, public hearings and an appellate mechanism that respects the jurisdiction of EU and national courts, the committee said.

Filed Under: IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Copyright Policy, Enforcement, English, Europe, Health & IP, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, WTO/TRIPS

140+ NGOs Urge WTO Members To Grant Extension Of LDC Pharma Waiver

29/05/2015 by Catherine Saez, Intellectual Property Watch 3 Comments

Over 140 non-governmental organisations, most of them local from developing countries, have co-signed a letter to World Trade Organization members to ask they agree to a request by least-developed countries to extend a waiver on their obligation to enforce intellectual property rights on pharmaceutical products.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

Lack Of Locally Relevant Online Content Deters Mobile Users In Developing Countries, WSIS Panel Says

28/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment

Although most people in the world live within reach of a mobile internet signal, a considerable amount of mobile users in developing countries are not using the opportunity to go online. One of the factors, according to a panel today, is the lack of locally relevant content.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Africa, Asia/Pacific, Copyright Policy, Development, English, ITU/ICANN, Information and Communications Technology/ Broadcasting, Innovation/ R&D, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

Panel: Compulsory Licensing Could Address High-Priced Medicines In Europe

28/05/2015 by Eimear Murphy for Intellectual Property Watch 3 Comments

The high prices of medicine, which affects access to affordable medicine, was a theme of the annual World Health Assembly over the past week. In one side event, a panel discussed compulsory licensing as a vehicle to be used in combatting the high prices of medicine, not only in developing countries, but in Europe.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Europe, Finance, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WHO

World Health Assembly Concludes With Actions On Range Of Issues

27/05/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment

The 68th World Health Assembly (WHA), which took place from 18-26 May, was characterised as one of the most successful annual assemblies ever by Margaret Chan, World Health Organization director general. From the standpoint of intellectual property, access and innovation, this may be debatable. Below is a guide to the main accomplishments highlighted by Intellectual Property Watch.

These include: action plans to fight antibiotic resistance and to boost vaccinations, extension of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA), incremental progress on alternative research and development for neglected diseases, status of the pandemic influenza preparedness framework, response to emergencies like Ebola, and WHO’s relationship with lobbyists and donors.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WHO

WHO Engagement With Non-State Actors: No Deal This Year, Work To Continue

26/05/2015 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment

The annual World Health Assembly closed today following a decision to postpone for one year completion of a new policy on the UN agency’s engagement with industry, foundations and other “non-state actors.”

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WHO

WHA Committees Approve Plans On Antimicrobial Resistance, Vaccines, Innovation

25/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment

Today, member states in committee at the World Health Assembly adopted the first global plan of action to address the issue of antimicrobial resistance, and a global plan of action on vaccines. In addition, a mechanism on public health, innovation and intellectual property was postponed until 2022, and a deadline for its evaluation moved to 2018.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

An Interview With WIPO Director General Francis Gurry On The New Lisbon Act For GIs

25/05/2015 by Catherine Saez, Intellectual Property Watch 1 Comment

Members of the Lisbon Agreement for the Protection of Appellations of Origin and their International Registration on 20 May agreed on a new Act of the agreement, extending protection previously granted only to appellations of origins to geographical indications. The World Intellectual Property Organization is responsible for this agreement. After the signing ceremony at WIPO, Intellectual Property Watch sat down with WIPO Director General Francis Gurry to discuss the new Act.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Enforcement, English, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, WIPO

WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable

25/05/2015 by William New, Intellectual Property Watch 1 Comment

The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Finance, Health & IP, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

WHO Advances R&D Financing Effort; Global R&D Observatory To Launch In January

24/05/2015 by Catherine Saez and William New, Intellectual Property Watch 2 Comments

World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2019 · Global Policy Reporting